Log inSign up
AviadoBio
406 posts
AviadoBio profile banner
@AviadoBio

AviadoBio

@AviadoBio
Translating groundbreaking science and precision delivery into life-changing medicines for people living with devastating neurodegenerative diseases.
London, Greater London
aviadobio.com
Joined July 2021
117
Following
348
Followers
RepliesRepliesRepostsRepostsMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • Pinned
    @AviadoBio
    AviadoBio
    @AviadoBio
    Oct 9, 2025
    We’re thrilled to announce our new exclusive option-license agreement with UgeneX Therapeutics for UGX-202, a novel, investigational #GeneTherapy designed to potentially restore vision in people living with #RetinitisPigmentosa and other retinal diseases. tinyurl.com/33v2jpyj
    Image
  • @AviadoBio
    AviadoBio
    @AviadoBio
    Sep 3
    This #WorldAlzheimersMonth, we recognize the patients, families and caregivers whose lives are drastically changed by Alzheimer’s disease and related dementias. We stand with this community and remain committed to pursuing new possibilities in neurodegenerative disease. #ALZ
    Image
  • @AviadoBio
    AviadoBio
    @AviadoBio
    Aug 19
    #DYK that you can speak with a genetic counselor before inquiring about genetic testing? @KatieBrandt6 tells us more about the importance of connecting with a genetic counselor and how they can help you navigate your personal journey. #GeneticCounseling #FTD
    Image
    00:00
  • @AviadoBio
    AviadoBio
    @AviadoBio
    Aug 4
    We’ve always been united by one purpose: to create potentially life-changing medicines for people living with neurodegenerative diseases. No matter the role, each team member brings us one step closer to delivering on our promise. Read more: aviadobio.com #TeamCulture
    Image
  • @AviadoBio
    AviadoBio
    @AviadoBio
    Jul 17
    What a week at #AAIC! It was an incredible gathering of minds advancing research in Alzheimer’s disease and related dementias. A highlight for us was sharing data across two programs—AVB-101 targeting FTD and AVB-406 targeting Alzheimer’s & other tauopathies. @alzassociation
    Image
Advertisement
Advertisement